Citalopram hydrobromi
Open Solicitation Posted
- Solicitation number
- SPE2DP27T0218
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- More information
Notice details come from SAM.gov. Updated .
About this opportunity
Defense Logistics Agency Troop Support Medical seeks quotes for one bottle of Citalopram Hydrobromide tablets (NSN 6505-01-505-4632) under Request for Quotations SPE2DP27T0218, with quotes due November 9, 2026 via the DLA Internet Bid Board System (DIBBS). The Set Aside line reads No Set-Aside Used, and the solicitation type is Fast Auto Evaluation.
The line item is 20 mg, 100-count, under PR 7018955362. The source places delivery within 5 days from award to a U.S. Army facility in Powidz, Poland, on FOB destination terms with inspection and acceptance at destination. Quantity is one bottle, and offerors are advised to submit quantity ranges because of demand volatility. The bulk break point is W9005D. The solicitation provides for automated award for this micro-purchase acquisition unless first article test requirements apply. No evaluation weighting is stated.
The item is FDA-regulated, stored at 25°C with permitted excursions to 15-30°C, and carries a 36-month non-extendable shelf life. Technical and quality requirements reference the DLA Technical and Quality Master List. Packaging, preservation, and marking follow MIL-STD-2073-1E and Medical Marking Standard No. 1. Qualified manufacturers include Mylan Pharmaceuticals Inc., Allergan USA Inc., and Golden State Medical Supply, Inc. The RFQ incorporates Berry Amendment and Buy American compliance, U.S.-flag vessel requirements for sea transport, safeguarding of covered defense information, hazard warning label requirements, telecommunications equipment prohibitions, and payment through Wide Area Workflow (WAWF). Recent awards for this item show unit costs ranging from $3.44 to $6.39. The product service code is 6505, Drugs and Biologicals.
Notice text
DLA request for quotation SPE2DP27T0218, issued by DLA office SPE2DP through DIBBS. Quotes are due by 11/09/2026. Set-aside: No Set-Aside Used. Solicitation type: Fast Auto Evaluation. FOB Destination. Inspection at Destination. Item: line 0001, CITALOPRAM HYDROBROMI, NSN 6505-01-505-4632, 1 BT, delivery in 5 days, PR 7018955362. Quotes must be submitted via DIBBS.
Files
| File | Type | Posted |
|---|---|---|
| SPE2DP27T0218.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Brincidofovir oral SU | Medical Supply Chain | No set-aside | |
| Loratadine tablets | Medical Supply Chain | No set-aside | |
| Sodium chloride injec | Medical Supply Chain | No set-aside | |
| Isoniazid tablets | Medical Supply Chain | No set-aside | |
| Simethicone tablets | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity